Erdosteine is effective as a treatment for acute exacerbation of COPD: a systematic review of clinical trials

Conclusions: Treatment with Erdosteine plus standard therapy in AECOPD is effective by improving both clinical symptoms, and large airway impairment with a more rapid and complete recovery of exacerbation compared with placebo. Mucoactive agents with relevant antioxidant activity may allow a more rapid and complete recovery of exacerbated patients by reducing airway inflammation.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Clinical Problems COPD Source Type: research